Hyperfine makes MRI accessible to every patient regardless of income or resources.
Hyperfine is the groundbreaking medical device company that created Swoop®, the world’s first FDA-cleared point-of-care MRI system. Hyperfine designed Swoop to enable rapid diagnoses and treatment for every patient regardless of income, resources, or location, pushing the boundaries of conventional imaging technology and expanding patient access to life-saving care. The Swoop Portable MR Imaging System™ produces high-quality images at a low magnetic field strength, allowing clinicians to quickly scan, diagnose, and treat patients in various clinical settings. Swoop can be wheeled directly to the patient’s bedside, plugged into a standard electrical wall outlet, and controlled by an iPad®. Designed as a complementary system to conventional MRIs at a fraction of the cost, Swoop captures images in minutes, providing critical decision-making capabilities in emergency departments, operating rooms outside the sterile field, and intensive care units, among others.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 10, 2021 | Series D | $90M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Colle Capital Partners | — | Series D |
Axiom Associates | — | Series D |